Samsara BioCapital »

Jasper Therapeuritc shares owned by Samsara BioCapital

Quarter-by-quarter ownership of Jasper Therapeuritc (JSPR) shares owned by Samsara BioCapital from 13F filings

Historical chart of Samsara BioCapital investment in Jasper Therapeuritc

Tip: Access up to 7 years of quarterly data

All positions including Jasper Therapeuritc held by Samsara BioCapital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jasper Therapeuritc by Samsara BioCapital

Quarter filed Position value Share count Share price at filing
2024-03-31 $15M 525k 29.36

More positions owned by Samsara BioCapital

Scholar Rock Hldg Corp (SRRK)
Cargo Therapeutics (CRGX)
Mineralys Therapeutics (MLYS)
Neurogene (NGNE)
Nkarta (NKTX)
Arcellx Common Stock (ACLX)
Lenz Therapeutics
Lyra Therapeutics (LYRA)
Acelyrin (SLRN)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Jasper Therapeutics Com New (JSPR)
Zymeworks Del (ZYME)
Hillevax (HLVX)
Abivax Sa Sponsored Ads (ABVX)
Inozyme Pharma (INZY)

View all positions for Samsara BioCapital

Top funds holding Jasper Therapeuritc

Velan Capital Investment Management
Soleus Capital Management
Carlyle
Avidity Partners Management
Franklin Resources
Vanguard Group
Samsara BioCapital
Sphera Funds Management
Octagon Capital Advisors
Kingdon Capital Management
Opaleye Management
Dr. Jeffrey R. Jay, M.D.
Rock Springs Capital Management
Woodline Partners
Boxer Capital

View all funds holding Jasper Therapeuritc